Related references
Note: Only part of the references are listed.In Vitro Synergistic Effect of Amphotericin B and Allicin on Leishmania donovani and L. infantum
M. J. Corral et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Immunoadjuvant Chemotherapy of Visceral Leishmaniasis in Hamsters Using Amphotericin B-Encapsulated Nanoemulsion Template-Based Chitosan Nanocapsules
Shalini Asthana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Richard J. Hamill
DRUGS (2013)
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Bidyut Purkait et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum
Ma. Jesus Corral-Caridad et al.
EXPERIMENTAL PARASITOLOGY (2012)
Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses
Reema Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Allicin enhances host pro-inflammatory immune responses and protects against acute murine malaria infection
Yonghui Feng et al.
MALARIA JOURNAL (2012)
Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs
Young-Sun Kim et al.
PLOS ONE (2012)
Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: Leishman Donovan Units'' versus Real-Time PCR
Nadia das Dores Moreira et al.
PLOS ONE (2012)
A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis
Amitabha Chattopadhyay et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Leishmania Mitochondrial Peroxiredoxin Plays a Crucial Peroxidase-Unrelated Role during Infection: Insight into Its Novel Chaperone Activity
Helena Castro et al.
PLOS PATHOGENS (2011)
Amphotericin B inhibits entry of Leishmania donovani into primary macrophages
Yamuna Devi Paila et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Allicin and derivates are cysteine protease inhibitors with antiparasitic activity
Thilo Waag et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Drug Resistance in Leishmaniasis
Jaya Chakravarty et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin
Hasibagan Borjihan et al.
JOURNAL OF ANTIBIOTICS (2009)
Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis
Mukesh Samant et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhancement of the Fungicidal Activity of Amphotericin B by Allicin: Effects on Intracellular Ergosterol Trafficking
Akira Ogita et al.
PLANTA MEDICA (2009)
Amphotericin B: side effects and toxicity
Rafael Laniado-Laborin et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
Antileishmanial activity of nano-amphotericin B deoxycholate
Krishna Das Manandhar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for In vivo testing of antileishmanial compounds
M. A. Dea-Ayuela et al.
VETERINARY RESEARCH COMMUNICATIONS (2007)
Advances and perspectives in Leishmania cell based drug-screening procedures
D. Sereno et al.
PARASITOLOGY INTERNATIONAL (2007)
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation
SR Iñiguez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs
K Seifert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Cholesterol is required for Leishmania donovani infection:: implications in leishmaniasis
TJ Pucadyil et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2004)
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis
HW Murray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The hamster as a model of human visceral leishmaniasis: Progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response
PC Melby et al.
JOURNAL OF IMMUNOLOGY (2001)
Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model
JM Requena et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2000)
Share Paper
